PharVision Advisers’s Box BOX Stock Holding History

PharVision Advisers’s Portfolio BOX Stock Details BOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,005	Closed	-$342K	–	671
2025 Q2	$342K	Buy	+10,005	New	+$328K	0.49%	56

Other funds holding BOX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PharVision Advisers's BOX Position: Q3 2025 in Review

PharVision Advisers sold out of Box (BOX) in Q3 2025, closing a stake of 10,005 shares — an estimated $342K sold.

PharVision Advisers first reported a position in BOX in Q2 2025 and held it in 1 quarter. The position peaked at $342K in Q2 2025. 408 funds tracked by Wall St. Rank hold BOX as of Q3 2025.

PharVision Advisers reported no remaining Box position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 10,005 Box shares in Q3 2025, an estimated $342K.
PharVision Advisers first reported a position in Box in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Box position peaked at $342K in Q2 2025.
408 funds tracked by Wall St. Rank held Box as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.